| Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study RB Postuma, A Iranzo, M Hu, B Högl, BF Boeve, R Manni, WH Oertel, ... Brain 142 (3), 744-759, 2019 | 743 | 2019 |
| Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease M Rolinski, C Fox, I Maidment, R McShane Cochrane Database Syst Rev 3, 2012 | 527 | 2012 |
| Alpha‐synuclein RT‐Qu IC in the CSF of patients with alpha‐synucleinopathies G Fairfoul, LI McGuire, S Pal, JW Ironside, J Neumann, S Christie, ... Annals of clinical and translational neurology 3 (10), 812-818, 2016 | 476 | 2016 |
| Predictors of cognitive impairment in an early stage Parkinson's disease cohort MTM Hu, K Szewczyk‐Królikowski, P Tomlinson, K Nithi, M Rolinski, ... Movement Disorders 29 (3), 351-359, 2014 | 198 | 2014 |
| Functional connectivity in the basal ganglia network differentiates PD patients from controls K Szewczyk-Krolikowski, RAL Menke, M Rolinski, E Duff, ... Neurology 83 (3), 208-214, 2014 | 197 | 2014 |
| REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease M Rolinski, K Szewczyk-Krolikowski, PR Tomlinson, K Nithi, K Talbot, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (5), 560-566, 2014 | 189 | 2014 |
| Prodromal parkinsonism and neurodegenerative risk stratification in REM sleep behavior disorder TR Barber, M Lawton, M Rolinski, S Evetts, F Baig, C Ruffmann, A Gornall, ... Sleep 40 (8), zsx071, 2017 | 172 | 2017 |
| Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder MG Miglis, CH Adler, E Antelmi, D Arnaldi, L Baldelli, BF Boeve, M Cesari, ... The Lancet Neurology 20 (8), 671-684, 2021 | 148 | 2021 |
| Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease M Rolinski, L Griffanti, P Piccini, AA Roussakis, K Szewczyk-Krolikowski, ... Brain 139 (8), 2224-2234, 2016 | 141 | 2016 |
| Parkinson’s disease subtypes in the Oxford Parkinson Disease Centre (OPDC) discovery cohort M Lawton, F Baig, M Rolinski, C Ruffman, K Nithi, MT May, Y Ben-Shlomo, ... Journal of Parkinson's Disease 5 (2), 269-279, 2015 | 115 | 2015 |
| Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD S Arora, F Baig, C Lo, TR Barber, MA Lawton, A Zhan, M Rolinski, ... Neurology 91 (16), e1528-e1538, 2018 | 106 | 2018 |
| Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells AM Smith, C Depp, BJ Ryan, GI Johnston, J Alegre‐Abarrategui, S Evetts, ... Movement Disorders 33 (10), 1580-1590, 2018 | 91 | 2018 |
| Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder D Arnaldi, A Chincarini, MT Hu, K Sonka, B Boeve, T Miyamoto, ... Brain 144 (1), 278-287, 2021 | 88 | 2021 |
| Challenges in the reproducibility of clinical studies with resting state fMRI: An example in early Parkinson's disease L Griffanti, M Rolinski, K Szewczyk-Krolikowski, RA Menke, N Filippini, ... Neuroimage 124, 704-713, 2016 | 87 | 2016 |
| Delineating nonmotor symptoms in early Parkinson's disease and first‐degree relatives F Baig, M Lawton, M Rolinski, C Ruffmann, K Nithi, SG Evetts, ... Movement Disorders 30 (13), 1759-1766, 2015 | 79 | 2015 |
| Impulse control disorders in Parkinson disease and RBD: a longitudinal study of severity F Baig, MJ Kelly, MA Lawton, C Ruffmann, M Rolinski, JC Klein, T Barber, ... Neurology 93 (7), e675-e687, 2019 | 66 | 2019 |
| Aberrant functional connectivity within the basal ganglia of patients with Parkinson's disease M Rolinski, L Griffanti, K Szewczyk-Krolikowski, RAL Menke, GK Wilcock, ... NeuroImage: Clinical 8, 126-132, 2015 | 61 | 2015 |
| Systematic review looking at the use of technology to measure free-living symptom and activity outcomes in Parkinson’s disease in the home or a home-like environment C Morgan, M Rolinski, R McNaney, B Jones, L Rochester, W Maetzler, ... Journal of Parkinson's disease 10 (2), 429-454, 2020 | 60 | 2020 |
| Modulation of hippocampal theta and hippocampal‐prefrontal cortex function by a schizophrenia risk gene H Cousijn, EM Tunbridge, M Rolinski, G Wallis, GL Colclough, ... Human brain mapping 36 (6), 2387-2395, 2015 | 51 | 2015 |
| Visual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson’s disease M Rolinski, N Zokaei, F Baig, K Giehl, T Quinnell, Z Zaiwalla, CE Mackay, ... Brain 139 (1), 47-53, 2016 | 49 | 2016 |
Michele HuNuffield Department Clinical Neurosciences, University of Oxford在 ndcn.ox.ac.uk 的电子邮件经过验证
